期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 61, 期 5, 页码 2111-2117出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.7b01824
关键词
-
资金
- Wellcome Trust Investigator award [099266/Z/12/Z]
- Wellcome Trust Pathfinder award [200983/Z/16/Z]
- Wellcome Trust [200983/Z/16/Z, 099266/Z/12/Z] Funding Source: Wellcome Trust
The aryloxy triester phosphoramidate prodrug approach has been used with success in drug discovery. Herein, we describe the first application of this prodrug technology to the monophosphate derivative of the phosphoantigen HMBPP and one of its analogues. Some of these prodrugs exhibited specific and potent activation of V gamma 9/V delta 2 T-cells, which were then able to lyse bladder cancer cells in vitro. This work highlights the promise of this prodrug technology in the discovery of novel immunotherapeutics.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据